Code | 3800A | ||||||||||
MA number | 10/0015/13-S | ||||||||||
Product Form: | tbl 100x400 mg (tuba PP/PE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | GlaxoSmithKline Trading Services Limited, Ireland | ||||||||||
Therapeutic Class: | 10 - ANTHELMINTICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 60 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - known active substance |
MA issued: | 23.01.2013 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
PIL: |
|
SPC: |
|
Safety feature | Yes |
Data update: | 15.05.2018 |